Get started
Author

Domenico Ravazza

Observed names: RAVAZZA, DOMENICO, Ravazza, Domenico
ORCID: 0009-0006-5739-8090
Observed ORCID: 0009-0006-5739-8090
OpenAlex ID: A5091475310
Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma
2023 · Thomas Look, Emanuele Puca, et al. · Science Translational Medicine · 46
Preclinical Evaluation of 177 Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors
2024 · Andrea Galbiati, Matilde Bocci, et al. · Journal of Nuclear Medicine · 44
PDF
A Comparative Analysis of Fibroblast Activation Protein-Targeted Small Molecule–Drug, Antibody–Drug, and Peptide–Drug Conjugates
2023 · Aureliano Zana, Claudia Puig-Moreno, et al. · Bioconjugate Chemistry · 35
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors
2024 · Giulia Rotta, Ettore Gilardoni, et al. · EMBO Molecular Medicine · 10
PDF
An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade
2024 · Cesare Di Nitto, Domenico Ravazza, et al. · Journal for ImmunoTherapy of Cancer · 9
Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker
2023 · Lydia Bisbal Lopez, Domenico Ravazza, et al. · Frontiers in Pharmacology · 7
Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein
2026 · Matilde Bocci, Laura Lucaroni, et al. · Molecular Pharmaceutics · 3
Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer
2025 · Justin S. Hachey, Tara D. Viray, et al. · Journal of Nuclear Medicine · 3
Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix–Targeted Radiopharmaceutical against Triple-Negative Breast Cancer
2026 · Justin S. Hachey, Tara D. Viray, et al. · Clinical Cancer Research · 2
Abstract 5744: Decreasing toxicity of immunocytokines by transient and selective inhibition of their intracellular signaling activation
2023 · Giulia Rotta, Ettore Gilardoni, et al. · Cancer Research · 2
Generation and characterization of novel high-affinity fully human antibodies targeting prostate-specific membrane antigen and prostatic acid phosphatase
2025 · Claudia Comacchio, Stefanie K Pfister, et al. · Antibody Therapeutics · 1
PDF
Quantitative Mass Spectrometry-Based Biodistribution of Monoclonal Antibodies: An Alternative to Radio-Biodistribution
2026 · Ravazza, Domenico, Plaza, Sheila Dakhel, et al. · ETH Zürich Research Collection
Quantitative Mass Spectrometry‐Based Biodistribution of Monoclonal Antibodies: An Alternative to Radio‐Biodistribution
2026 · Domenico Ravazza, Sheila Dakhel Plaza, et al. · Advanced Science
Supplementary Data1 from Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix–Targeted Radiopharmaceutical against Triple-Negative Breast Cancer
2026 · Justin S. Hachey, Tara D. Viray, et al.
Data from Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix–Targeted Radiopharmaceutical against Triple-Negative Breast Cancer
2026 · Justin S. Hachey, Tara D. Viray, et al.
Generation and characterization of novel high-affinity fully human antibodies targeting prostate-specific membrane antigen and prostatic acid phosphatase
2025 · Comacchio, Claudia, Pfister, Stefanie K, et al. · Zurich Open Repository and Archive (University of Zurich)
Abstract 4781: Generation and in vivo characterization of a novel antibody targeting Prostatic Acid Phosphatase (ACP-3)
2025 · Claudia Comacchio, Stefanie Pfister, et al. · Cancer Research
Works count: 18
Citation count: 162
H-index: 6
I10-index: 4
Year
Topic
Type